Abstract
Introduction
Intra-arterial papaverine (IAP) is used to treat symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH). IAP, however, can increase intracranial pressure (ICP). In this study we examined whether IAP alters brain oxygen (BtO2).
Methods
Poor clinical grade (Hunt & Hess IV or V) SAH patients who underwent continuous ICP and BtO2 monitoring during IAP infusion for symptomatic cerebral vasospasm were evaluated as part of a prospective observational study.
Results
Data are available for five patients (median age 58) who received IAP for cerebral vasospasm 4 to 7 days after SAH. In each patient, angiographic vasospasm was improved on postinfusion angiogram. Mean ICP before IAP was 23.04±1.18 mmHg; it increased immediately after IAP infusion and remained elevated (29.89±1.18 mmHg; p<0.05) during IAP and for approximately 10 minutes after IAP ended. Baseline mean arterial pressure (MAP) was 110.55±1.36 mmHg. During IAP treatment MAP remained stable (110.90±2.00 mmHg; p=0.31). Mean BtO2 before IAP was 32.99±1.45 mmHg. There was a significant BtO2 decrease in all patients during IAP to a mean of 22.96±2.9 mmHg (p<0.05). BtO2 returned to baseline within 10 minutes after IAP ended. There was a modest relationship between the ICP increase and BtO2 decrease (R 2=0.526).
Conclusion
IAP infusion to treat cerebral vasospasm following SAH can increase ICP and reduce BtO2. The IAP-induced reduction in BtO2 may help explain why IAP, although it reverses arterial narrowing, does not improve patient outcome.
Article PDF
Similar content being viewed by others
References
Jahromi B, MacDonald RL. Vasospasm: Diagnosis and medical management. In: LeRoux P, Winn HR, Newell DW, eds Management of Cerebral Aneurysms. Philadelphia: Elsevier Science, 2004:455–488.
Scroop R, Britz G, West A, Eskridge J. Endovascular therapy for vasospasm associated with subarachnoid hemorrhage. In: LeRoux P, Winn HR, Newell DW, eds. Management of Cerebral Aneurysms. Philadelphia: Elsevier Science, 2004:489–498.
Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88(2):277–284.
Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992; 77(6):842–847.
Katoh H, Shima K, Shimizu A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 1999;21(2):195–203.
Liu JK, Tenner MS, Oestreich HM, Couldwell WT. Reversal of radiographically impending stroke with multiple intraarterial papaverine infusions in severe diffuse cerebral vasospasm induced by subarachnoid hemorrhage. Acta Neurochir 2001; 143(12):1249–1255.
Liu JK, Tenner MS, Gottfried ON, et al. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 2004;100(3):414–421.
Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:654–660.
Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intraarterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42(6):1256–1264.
Sawada M, Hashimoto N, Tsukahara T, Nishi S, Kaku Y, Yoshimura S. Effectiveness of intra-arterially infused paraverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir 1997;139(8):706–711.
Cross DT III, Moran CJ, Angtuaco EE, Milburn JM, Diringer MN, Dacey RG Jr. Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. Am J Neuroradiol 1998;19(7):1319–1323.
Smith WS, Dowd CF, Johnston SC, et al. Neurotoxicity of intraarterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasoapasm after aneurysmal subarachnoid hemorrhage. Stroke 2004;35(11):2518–2522.
Heuer G, Smith MJ, Elliott JP, Winn HR, Le Roux P.. The relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage. J Neurosurgery 2004;101:408–416.
Gopinath SP, Robertson CS, Contant CF, et al. Jugular venous desaturation and outcome after head injury. J Neurol Neurosurg Psychiatry 1994;57:717–723.
Gracias VH, Guillamondegui OD, Stiefel MF, et al. Cerebral cortical oxygenation: a pilot study. J Trauma 2004;56:469–474.
Le Roux P, Lam AM, Newell DW, Grady MS, Winn HR. Cerebral arteriovenous difference of oxygen: a predictor of cerebral infarction and outcome in severe head injury. J Neurosurg 1997;87:1–8.
van Santbrink H, van den Brink WA, Steyerberg EW, Carmona Suazo JA, Avezaat CJ, Maas AI. Brain tissue oxygen response in severe traumatic brain injury. Acta Neurochir (Wien) 2003;145(6):428–438.
Bardt TF, Unterberg AW, Hartl R, Kiening KL, Schneider GH, Lanksch WR. Monitoring of brain tissue PO2 in traumatic brain injury: effect of cerebral hypoxia on outcome. Acta Neurochir Suppl 1998;71:153–156.
Johnson AJ, Steiner LA, Coles JP, et al. Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury. Crit Care Med 2005;33(1):189–195.
van den Brink WA, van Santbrink H, Steyerberg EW, et al. Brain oxygen tension in severe head injury. Neurosurgery 2000;46(4):868–876.
Vath A, Meixensberger J, Dings J, Roosen K. Advanced neuromonitoring including cerebral tissue oxygenation and outcome after traumatic brain injury. Neurol Res 2001;23(4):315–320.
Le Roux P, Winn HR. Management of the ruptured aneurysm. In: Le Roux P, Winn HR, Newell DW, eds. Management of Cerebral Aneurysms. Philadelphia: Elsevier Science, 2004:303–333.
McKhann GM, Mayer, S, Le Roux P. Perioperative and ICU care of patients with aneurysmal subarachnoid hemorrhage. In: Le Roux P, Winn HR, Newell DW, eds. Management of Cerebral Aneurysms. Philadelphia: Elsevier Science, 2004:431–454.
McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR. Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg 1995; 83(3):430–434.
Carmona Suazo JA, Maas AI, van den Brink WA, van Santbrink H, Steyerberg EW, Avezaat CJ. CO2 reactivity and brain oxygen pressure monitoring in severe head injury. Crit Care Med 2000;28:3268–3274.
Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongabie GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg 1990;73(1):18–36.
Schuknecht B, Fandino J, Yuksel C, Yonekawa Y, Valavanis A, Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology 1999;41(6):453–462.
Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papavenne for the treatment of cerebral vasospasm. J Neurosurg 1998;89(1):93–100.
Clay HD. Validity and reliability of the SjO2 catheter in neurologically impaired patients: a critical review of the literature. J Neurosci Nurs 2000;32(4):194–203.
Reisch R, Filippi R, Bocher-Schwarz H, et al. Effect of intraarterial infusion of papaverine hydrochloride on brain tissue oxygen pressure in the management of severe vasospasm following aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2001;77:191–193.
Menon DK, Coles JP, Gupta AK, et al. Diffusion limited oxygen delivery following head injury. Crit Care Med 2004;32(6):1384–1390.
Critchley GR, Bell BA. Acute cerebral tissue oxygenation changes following experimental subarachnoid hemorrhage. Neurol Res 2003;25(5):451–456.
Vajkoczy P, Horn P, Bauhuf C, et al. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 2001;32(2):498–505.
Meixensberger J, Vath A, Jaeger M, Kunze E, Dings J, Roosen K. Monitoring of brain tissue oxygenation following severe subarachnoid hemorrhage. Neurol Res 2003;25(5):445–450.
Soehle M, Jaeger M, Meixensberger J. Online assessment of brain tissue oxygen autoregulation in traumatic brain injury and subarachnoid hemorrhage. Neurol Res 2003;25(4):411–417.
Enblad P, Persson L. Impact on clinical outcome of secondary brain insults during the neurointensive care of patients with subarachnoid haemorrhage: a pilot study. J Neurol Neurosurg Psychiatry 1997;62(5):512–516.
Meixensberger J, Jaeger M, Vath A, Dings J, Kunze E, Roosen K. Brain tissue oxygen guided treatment supplementing ICP/CPP therapy after traumatic brain injury. J Neurol Neurosurg Psychiatry 2003;74(6):760–764.
Stiefel MF, Gracias VH, Garuffe A., et al. Brain tissue oxygen directed management reduces mortality in patients with severe traumatic brain injury. J Neurosurgery 2005;103:805–811.
Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary Experience with Intra-Arterial Nicardipine as a Treatment for Cérebral Vasospasm. Am J Neuroradiol 2004;25(5):819–826.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stiefel, M.F., Spiotta, A.M., Udoetuk, J.D. et al. Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen. Neurocrit Care 4, 113–118 (2006). https://doi.org/10.1385/NCC:4:2:113
Issue Date:
DOI: https://doi.org/10.1385/NCC:4:2:113